Aimei Health Technology Stock Net Income
| AFJK Stock | 48.00 3.99 9.07% |
Aimei Health's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Aimei Stock price.
| Last Reported | Projected for Next Year | ||
| Net Income | 2.6 M | 1.5 M | |
| Net Income From Continuing Ops | 2.3 M | 2 M | |
| Net Income Per Share | 0.28 | 0.30 |
Aimei Health Technology Company Net Income Analysis
Aimei Health's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Aimei Health Net Income | 2.55 M |
Most of Aimei Health's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aimei Health Technology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Aimei Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Aimei Health is extremely important. It helps to project a fair market value of Aimei Stock properly, considering its historical fundamentals such as Net Income. Since Aimei Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aimei Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aimei Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Aimei Health Technology reported net income of 2.55 M. This is 99.8% lower than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 99.55% higher than that of the company.
Aimei Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aimei Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aimei Health could also be used in its relative valuation, which is a method of valuing Aimei Health by comparing valuation metrics of similar companies.Aimei Health is currently under evaluation in net income category among its peers.
Aimei Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Aimei Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Aimei Health's managers, analysts, and investors.Environmental | Governance | Social |
Aimei Fundamentals
| Return On Asset | -0.0104 | ||||
| Current Valuation | 271.07 M | ||||
| Shares Outstanding | 6.12 M | ||||
| Shares Owned By Insiders | 33.60 % | ||||
| Shares Owned By Institutions | 60.19 % | ||||
| Number Of Shares Shorted | 5 K | ||||
| Price To Book | 6.41 X | ||||
| EBITDA | (1.06 M) | ||||
| Net Income | 2.55 M | ||||
| Total Debt | 227.7 K | ||||
| Book Value Per Share | (0.56) X | ||||
| Cash Flow From Operations | (672.29 K) | ||||
| Short Ratio | 0.18 X | ||||
| Earnings Per Share | 0.20 X | ||||
| Market Capitalization | 269.42 M | ||||
| Total Asset | 73.81 M | ||||
| Retained Earnings | (1.48 M) | ||||
| Working Capital | (786.61 K) | ||||
| Net Asset | 73.81 M |
About Aimei Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aimei Health Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aimei Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aimei Health Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Aimei Health Piotroski F Score and Aimei Health Altman Z Score analysis. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aimei Health. If investors know Aimei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aimei Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aimei Health Technology is measured differently than its book value, which is the value of Aimei that is recorded on the company's balance sheet. Investors also form their own opinion of Aimei Health's value that differs from its market value or its book value, called intrinsic value, which is Aimei Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aimei Health's market value can be influenced by many factors that don't directly affect Aimei Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aimei Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aimei Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aimei Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.